Patent application number | Description | Published |
20080242654 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - The present application relates to thiazolylidene containing compounds of formula (I) | 10-02-2008 |
20080287510 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - The present application relates to thiazolylidene containing compounds of formula (I) | 11-20-2008 |
20090023789 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - The present application relates to isothiazolylidene containing compounds of Formula (I) | 01-22-2009 |
20090105306 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - The present invention relates compounds of formula (I) | 04-23-2009 |
20090247500 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - Disclosed herein are compounds of formula (I) | 10-01-2009 |
20100063022 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - The present application relates to cannabinoid receptor ligands of formula (I) | 03-11-2010 |
20100069348 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - Disclosed herein are cannabinoid receptor ligands of formula (I) | 03-18-2010 |
20100069349 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - Disclosed herein are cannabinoid receptor ligands of formula (I) | 03-18-2010 |
20100093814 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF - The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, | 04-15-2010 |
20100216760 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - Disclosed herein are cannabinoid receptor ligands of formula (I) | 08-26-2010 |
20100234345 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - The present application relates to isothiazolylidene containing compounds of Formula (I) | 09-16-2010 |
20100249129 | COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - Disclosed herein are compounds of formula (I) | 09-30-2010 |
20100267738 | NOVEL AMIDE AND AMIDINE DERIVATIVES AND USES THEREOF - The present invention relates to inhibitors of 11-β-hydroxysteroid dehydrogenase type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids. | 10-21-2010 |
20100305109 | POTASSIUM CHANNEL MODULATORS - Disclosed herein are KCNQ potassium channels modulators of formula (I) | 12-02-2010 |
20110082116 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - The present application relates to isothiazolylidene containing compounds of Formula (I) | 04-07-2011 |
20110086832 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - The present application relates to thiazolylidene containing compounds of formula (I) | 04-14-2011 |
20110086855 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF - The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, | 04-14-2011 |
20110124642 | POTASSIUM CHANNEL MODULATORS - Disclosed herein are KCNQ potassium channels modulators of formula (I) | 05-26-2011 |
20120015929 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS - Disclosed herein are compounds of formula (I) | 01-19-2012 |
20120122890 | Potassium Channel Modulators - Disclosed herein are KCNQ potassium channels modulators of formula (I) | 05-17-2012 |
20120329772 | AMINO-TETRAZOLES ANALOGUES AND METHODS OF USE - A compound having Formula (I) or Formula (II) | 12-27-2012 |